Publication number: 20240166533
Abstract: A high-nickel ternary core-shell precursor for a lithium battery, a positive electrode material and a preparation method therefor. The chemical structural formula of the precursor is zNi(C4H7N2O2)2—Nix-zM1yM21-x-y(OH)2, wherein M1 and M2 are two of cobalt, aluminum, and manganese. The preparation method comprises: pumping a prepared metal salt solution, a dimethylglyoxime-ammonia water composite solution, and an ammonia water solution into a reaction kettle, maintaining the pH of a reaction system, and controlling the reaction time to obtain a sphere-like precursor inner core with a structural formula of Ni(C4H7N2O2)2; pumping the metal salt solution and the ammonia water solution, stopping pumping the dimethylglyoxime-ammonia water composite solution, pumping a sodium hydroxide solution to obtain a sphere-like core-shell precursor, washing, drying, sieving and deironing the precursor, mixing with a lithium source, and calcining to prepare the positive electrode material.
Type:
Application
Filed:
August 18, 2022
Publication date:
May 23, 2024
Applicant:
JINGMEN GEM CO., LTD.
Inventors:
Kaihua XU, Kun ZHANG, Dongming JIA, Cong LI, Xing YANG, Xiaofei XUE, Liangjiao FAN, Xiaofei CHEN, Xueqian LI, Xiaoshuai ZHU, Hao LV, Wenfang YUAN, Ding WANG, Xianjin YUE
Publication number: 20240140957
Abstract: Provided herein are Bridged Compounds having the following structures: wherein R1a, R1b, R1c, R1d, R2a, R2b, R2c, R2d, R3a, R3b, R3c, R3d, R4, R5, R6, R7, R8, m1, m2, m3, n2, n3, n4, q, X1, X2, Y1, Y2, L1 and ring A are as defined herein, compositions comprising an effective amount of a Bridged Compound, and methods for treating or preventing various diseases, e.g., pancreatic cancer, or a condition treatable or preventable by inhibition of the function of KRAS protein. In another aspect, a Bridged Compound is useful for treating or preventing a condition treatable or preventable by inhibition of the function of KRAS protein with G12D mutation. In another aspect, a Bridged Compound is useful for treating or preventing a condition treatable or preventable by inhibition of a RAS/MAPK pathway.
Type:
Application
Filed:
January 7, 2022
Publication date:
May 2, 2024
Inventors:
Qi JI, Chao YU, Ce WANG, Hanzi sun, Hao YUAN, Zhiwei WANG